This healthcare company is a prominent player in the pharmaceutical industry, specializing in a wide range of products including Active Pharmaceutical Ingredients (APIs), Biosimilars, Injectables, Ophthalmics, Peptides, and Solid Orals. They have a strong presence in both domestic and international markets, particularly in the EU and North America. The company boasts a diverse portfolio across several key therapy areas, with particular strength in Cardiovascular health and Oral Anti-Diabetic (OAD) medications. Their manufacturing facilities adhere to stringent GMP certifications, ensuring high quality standards. They also hold numerous product patents, highlighting their commitment to innovation.